Medtronic (Minneapolis) reported FDA clearance and the first U.S. clinical uses of its new Affinity Fusion oxygenation system. Due to the intense collaboration between the med-tech giant and those in the field that would use the technology, the device has the market tagline, designed by perfusionists, engineered by Medtronic.
It might be pretty simple to take a patient's blood pressure manually, but in some cases it can be tricky if not almost impossible to get an accurate reading. One of those situations stems from patients having their blood pressure taken during a stress test. One med-tech company, though, has designed a device to automate the process and said it has made blood pressure readings simpler and more accurate for clinicians during a stress test.
Three key trends in the med-tech sector could significantly shape the space throughout the next few years, according to Continuum (Boston), an innovation and design consultancy firm, that is dedicated to researching and designing devices that improve how medical professionals carry out their jobs.
Two things happened in January that really got the attention of a lot of people in this country - the payroll tax expired and in some cases insurance premiums went up. This cataclysmic effect sent many to Twitter and Facebook, ranting about how much money was being taken out of their monthly pay. While I could go on about the first blow, it might be more appropriate to talk about the second, being that this is a blog on the med-tech and healthcare industry. According to a report titled, "Cost of Comprehensive Health Benefits” from eHealth, the average monthly premiums...
It's an all too familiar scene in movies. A patient is in desperate need of a transplant, and the donor organ is miles away. In less than eight hours the organ won't be any good to the patient who is in dire straits. As this drama unfolds a transport team with the transplant is feverishly racing against the clock – and all odds – to get it to the intended recipient.
In a move to perhaps eliminate a significant portion of its debt, Angiotech Pharmaceuticals (Vancouver, British Columbia) reported the sale of its interventional products business to Argon Medical Devices (Plano, Texas) for $362.5 million.
